GlassScriptPhysician profile
Asif Husain
NPI 1578591160
$2,988.26
in general payments reported to CMS, 2019-2025
27 companies · $38.48 in 2025
The $38.48 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $688 · 2021: $371 · 2022: $113 · 2023: $644 · 2024: $568 · 2025: $38.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $468.29 | 2019-2024 | Entyvio, Gattex |
| Boston Scientific Corporation | $241.35 | 2019-2020 | |
| Allergan, INC. | $217.50 | 2020 | |
| Gilead Sciences, INC. | $214.88 | 2019-2024 | |
| Genzyme Corporation | $188.59 | 2023 | |
| Braintree Laboratories, INC. | $180.66 | 2019-2024 | Suflave, Sutab |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.61 | 2023 | Trulance |
| Redhill Biopharma INC. | $141.49 | 2021-2022 | |
| Ethicon US, LLC | $136.00 | 2019 | |
| Pfizer INC. | $121.34 | 2020 | |
| Anx Robotica Corp | $117.04 | 2024 | |
| Intercept Pharmaceuticals, INC. | $113.40 | 2024 | |
| Abbvie INC. | $110.85 | 2020-2022 | |
| Janssen Biotech, INC. | $104.64 | 2020-2023 | Stelara, Simponi Aria, Remicade |
| Medtronic, INC. | $89.44 | 2023 | Gi Genius |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $83.48 | 2022-2024 | Zeposia |
| Aimmune Therapeutics, INC. | $62.50 | 2023 | |
| Phathom Pharmaceuticals, INC. | $41.96 | 2024-2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $28.18 | 2024-2025 | |
| Echosens North America, INC. | $24.29 | 2024 | Fibroscan |
| Qol Medical, LLC | $23.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.36 | 2022 | |
| Capsovision, INC. | $21.31 | 2023 | Capsocam Plus |
| Sandoz INC. | $16.71 | 2024 | Hyrimoz |
| Organon LLC | $16.62 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.33 | 2022 | |
| Merck Sharp & Dohme LLC | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.